Search - tctmd.com

Displaying 21 - 40 of 94

Sort: Relevancy | Date

News Conference News EuroPCR 2016

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

Shelley Wood

May 26, 2016

News Conference News ACC 2016

New Insights Into MitraClip Performance in Both Functional and Degenerative MR Subtypes, as Use Expands

Shelley Wood

April 12, 2016

News Daily News

关于实验性高危心血管装置的研究越来越多

Shelley Wood

March 02, 2016

News Daily News

More Studies of Investigational High-Risk Cardiovascular Devices are Getting Published

Shelley Wood

March 02, 2016

News Daily News

Hay Cada Vez Más Estudios sobre Dispositivos Cardiovasculares de Alto Riesgo en Fase de Investigación

Shelley Wood

March 02, 2016

Presentation

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation (MR):5-Year results of EVEREST II

Presenter: Ted Feldman

December 21, 2015

News Daily News

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

L.A. McKeown

December 21, 2015

News Conference News TCT 2015

Experts Debate Mitral Valve Repair, Replacement for Intermediate-Risk Patients

October 12, 2015

Presentation TCT 2015

Five-Year Randomized EVEREST II Results: Where MitraClip Shined (and Where It Didnt)

Presenter: Stephan Baldus, Scott Lim, Ted E. Feldman

October 11, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Conference News ESC 2015

Registry Provides Support for Use of MitraClip in Lower-Risk Patients

L.A. McKeown

September 01, 2015

News Daily News

MVARC文件提供了二尖瓣治疗研究的模板

Todd Neale

July 16, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

El Documento MVARC Fija el Escenario para la Investigación Terapéutica de la Válvula Mitral

Todd Neale

July 16, 2015

Presentation TVT 2015

EVEREST II at 5 Years: Lessons Learned and Implications for Future Trials

Presenter: Paul A. Grayburn, Nicole Ibrahim, David L. Brown, Ted Feldman

June 05, 2015

Presentation TVT 2015

EVEREST II 5-Year Report: Beyond the Top-Line Results

Presenter: Antonio Colombo, Gregg W. Stone, Ted Feldman

June 04, 2015

Presentation TCT 2014

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Presenter: Saibal Kar

September 16, 2014

Presentation TCT 2014

Final 5-Year EVEREST II Results: Perspectives on What We Might Have Done Differently

Presenter: Olaf Franzen, James B. Hermiller Jr, Michael J. Rinaldi, Ted E. Feldman

September 13, 2014

Advertisement

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

New Insights Into MitraClip Performance in Both Functional and Degenerative MR Subtypes, as Use Expands

关于实验性高危心血管装置的研究越来越多

More Studies of Investigational High-Risk Cardiovascular Devices are Getting Published

Hay Cada Vez Más Estudios sobre Dispositivos Cardiovasculares de Alto Riesgo en Fase de Investigación

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation (MR):5-Year results of EVEREST II

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

Experts Debate Mitral Valve Repair, Replacement for Intermediate-Risk Patients

Five-Year Randomized EVEREST II Results: Where MitraClip Shined (and Where It Didnt)

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

Registry Provides Support for Use of MitraClip in Lower-Risk Patients

MVARC文件提供了二尖瓣治疗研究的模板

MVARC Document Offers Template for Mitral Valve Therapeutics Research

El Documento MVARC Fija el Escenario para la Investigación Terapéutica de la Válvula Mitral

EVEREST II at 5 Years: Lessons Learned and Implications for Future Trials

EVEREST II 5-Year Report: Beyond the Top-Line Results

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Final 5-Year EVEREST II Results: Perspectives on What We Might Have Done Differently

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content